Monitoring & Mitigation of Neurologic Injuries to Optimize Resilience After Repetitive Head Impacts
MONITOR-RHI
2 other identifiers
interventional
350
1 country
3
Brief Summary
The purpose of this Phase 2, double-arm study is to identify repetitive, non-concussive head impacts that impair neurologic functioning, and to test treatments that can mitigate these effects and return functioning to normal as quickly as possible.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2025
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 25, 2025
CompletedFirst Posted
Study publicly available on registry
February 5, 2025
CompletedStudy Start
First participant enrolled
July 23, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2029
September 11, 2025
September 1, 2025
4.4 years
January 25, 2025
September 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (10)
Optical Coherence Tomography (OCT) of Cerebrospinal Fluid Thickness in the Macula (Part of the Retina)
A primary OCT variables examined will be macula cerebrospinal fluid (CSF) thickness (an indicator of the gain or loss of neurons or glia in the inner nuclear, ganglion cell and nerve fiber layer).
Pre-season and post-season, 2 weeks
Change in Blood Serum Concentrations of Glial Fibrillary Acidic Protein (GFAP)
Glial Fibrillary Acidic Protein (GFAP) concentration will determine if there is a 11.9 pg/mL or greater change in GFAP in each participant over the course of the study.
Baseline 4 to 7 months
Change in Blood Serum Concentration of Neurofilament light chain (NfL) in a blood sample
The neurologic test battery consists of blood draws for serum brain proteins: Neurofilament light chain (NfL) concentrations will be observed for changes over the course of the study.
Baseline 4 to 7 months
Change in p-231Tau serum concentration in a blood sample
The neurologic test battery consists of blood draws for serum brain proteins: p231Tau will be observed for changes over the course of the study.
Baseline 4 to 7 months
Change in Concussion Index as measured with Quantitative Electroencephalogram (qEEG)
The Quantitative Electroencephalogram (qEEG) Concussion Index (CI) includes measures of power (absolute and relative), mean frequency, connectivity (asymmetry, coherence, phase lag, phase synchrony), complexity (fractal dimension and scale-free activity), and information theory (entropy), across and within frequency bands.
Baseline 4 to 7 months
Change in near-point convergence (NPC)
Near point of convergence (NPC) is a measurement of how close an object can be brought to the eyes while the eyes are focused on it.
Baseline 4 to 7 months
Change in Choice reaction time (CRT)
Choice reaction time (CRT) refers to the time it takes for a person to react to a stimulus by selecting a specific response from multiple options.
Baseline 4 to 7 months
Change in blink reflex test
A blink reflex test, also known as a corneal reflex test, is a non-invasive procedure that measures the electrical activity of the facial nerves when stimulated.
Baseline 4 to 7 months
Optical Coherence Tomography (OCT) to detect signs of neurodegenertaion in the Retina
OCT will be used to measure the cup-to-disc ratio of the optic disc, and indicator of neurodegeneration.
Pre-season and post-season, 2 weeks
Optical Coherence Tomography/Angiography (OCT/A) to assess the vascular structure in the retina
Retinal vascular structure will be acquired using the OCT angiography (OCT/A). The primary OCT/A variable examined will be foveal avascular zone (FAZ) area reflecting the size of the central portion of the macula which contains no blood vessels, and which increases in size with loss of capillaries in the surrounding region).
Pre-season and post-season, 2 weeks
Study Arms (2)
Observational (Ad-Lib Exercise) Arm
NO INTERVENTIONAll participants will undergo neurologic outcome testing with optical coherence tomography/angiography (OCT/A) at pre- and post-season and 2 weeks after the end of the season. For two weeks at the end of the sport season, participants will be instructed to refrain from sports involving head contact but to otherwise exercise ad-lib.
Intervention (Exercise or Stretching) Arm
EXPERIMENTALAthletes and athlete cadets will be administered OCT/A and a novel neurologic test battery at pre- and post-season, and 2 weeks after the end of the season. After the end-of-season assessments, participants will be randomized to 2 weeks of either 30 minutes of daily aerobic exercise or to 30-minutes of prescribed stretching.
Interventions
After the end-of-season assessments, participants in the Intervention (Exercise or Stretching) arm will be randomized to 2 weeks of daily aerobic exercise for 30 minutes or to 30-minutes of prescribed stretching.
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years
- Collegiate athlete or athlete-cadet anticipated to be an active member of a varsity sport team.
You may not qualify if:
- Any head, neck, or face injury in the 3 months prior to enrollment that precludes participation in contact sports or wearing a mouth guard sensor
- History of neurological or psychiatric disorders or neurological disorders that impact electrical activity in the brain (such as seizure disorders), or diagnosed learning disability, that in the opinion of the investigator, would interfere with participation in the study.
- Participants currently undergoing active treatment for migraine, depression and/or anxiety or ADHD will not be excluded as these are high prevalence conditions in the adolescent and collegiate population (8-30%). However, exploratory stratified analyses will be conducted where possible.
- Participants with eye conditions or diseases that could impact the blood vessels in the eye.
- Determination that the participant is unsuitable for study entry or potentially unable to complete all aspects of the study based on the judgement of the Site Investigator or Study PI.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
University at Buffalo
Amherst, New York, 14221, United States
University of Rochester
Rochester, New York, 14620, United States
The Citadel, The Military College of South Carolina
Charleston, South Carolina, 29409, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 25, 2025
First Posted
February 5, 2025
Study Start
July 23, 2025
Primary Completion (Estimated)
December 1, 2029
Study Completion (Estimated)
December 1, 2029
Last Updated
September 11, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share